Alprazolam tablets — Class II drug recall D-0326-2015
Terminated recall by Neolpharma, Inc., reported 2014-12-31, distributed nationwide. Subpotent Drug
| Recall number | D-0326-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Neolpharma, Inc., Caguas, PR, United States |
| Recall initiated | 2014-12-17 |
| Classified | 2014-12-24 |
| Reported by FDA | 2014-12-31 |
| Terminated | 2017-04-26 |
| Distributed | Nationwide (US) |
| Quantity | 12,310 bottles |
| Reason classes | potency |
| NDC | 59762-3719, 59762-3719-01, 59762-3719-03, 59762-3719-04, 59762-3720, 59762-3720-01, 59762-3720-03, 59762-3720-04, 59762-3721, 59762-3721-01, 59762-3721-03, 59762-3721-04, 59762-3722, 59762-3722-01, 59762-3722-03 |
Product
Alprazolam tablets, USP, CIV, 0.25 mg, Rx Only, a) 500 count bottle, b) 1000 count bottle, Distributed by: Greenstone LLC, Peapack, NJ, 07977, a) NDC 59762-3719-3, b) NDC 59762-3719-4.
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0326-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.